Nordhealth AS (NORDH.OL)
- Previous Close
35.80 - Open
37.00 - Bid 35.40 x --
- Ask 38.80 x --
- Day's Range
37.00 - 37.00 - 52 Week Range
29.00 - 45.80 - Volume
5 - Avg. Volume
6,953 - Market Cap (intraday)
2.925B - Beta (5Y Monthly) 0.46
- PE Ratio (TTM)
-- - EPS (TTM)
-1.16 - Earnings Date May 13, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
46.28
Nordhealth AS provides healthcare software solutions in Norway, Finland, Sweden, Denmark, Germany, and internationally. Its products include Provet Cloud, a veterinary practice management software (PMS); Diarium, a PMS for therapists that streamlines therapy sessions, booking, and invoicing; Physica, a PMS for physiotherapists; Psykbase, a PMS for psychologists and psychotherapists; EasyPractice, a PMS for therapists; and various PMS for veterinarians under the Vetserve, Sanimalis, Vetvision, and Vetera names. The company's products comprise Nordhealth Connect, a communication platform for patients and healthcare professionals; and Navisec, a digital learning environment for training and orientation. In addition, it offers services related to implementation of the SaaS systems, such as consultancy services, education, and data conversion. Further, the company provides nordhealth.fi, a consumer booking portal. The company was founded in 2001 and is based in Oslo, Norway.
nordhealth.com411
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NORDH.OL
View MorePerformance Overview: NORDH.OL
Trailing total returns as of 4/22/2025, which may include dividends or other distributions. Benchmark is OBX Total Return Index (OBX.OL) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NORDH.OL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NORDH.OL
View MoreValuation Measures
Market Cap
2.83B
Enterprise Value
2.56B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.16
Price/Book (mrq)
3.20
Enterprise Value/Revenue
4.65
Enterprise Value/EBITDA
50.38
Financial Highlights
Profitability and Income Statement
Profit Margin
-16.80%
Return on Assets (ttm)
-5.52%
Return on Equity (ttm)
-9.81%
Revenue (ttm)
45.67M
Net Income Avi to Common (ttm)
-7.67M
Diluted EPS (ttm)
-1.16
Balance Sheet and Cash Flow
Total Cash (mrq)
19.62M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-127.88k